🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchFLOW trial: semaglutide renal outcomes — need advice Page 5

FLOW trial: semaglutide renal outcomes — need advice

Dr.PainCLE Mon, Jan 19, 2026 at 9:08 PM 30 replies 843 viewsPage 5 of 6
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Jan 20, 2026 at 4:13 AM#21

Congrats Dr.PainCLE!! Keep going — you're doing incredible. 🎉

31 3FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 28 others
Reply Quote Save Share Report
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Jan 20, 2026 at 4:30 AM#22

Reading this thread on FLOW trial semaglutide hits close to home. Night shift nurse — I started at 287 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 62 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about FLOW trial semagluti — take the leap. It was the best health decision I have ever made. ❤️

34 19raj_cambridge, ingrid_STO, pete_nash and 31 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Jan 20, 2026 at 4:47 AM#23

As a pharmacist, I want to add some clinical context to this discussion on FLOW trial semaglutide renal outcomes .

Building on what CarlaRPh_TPA said — the evidence base here is robust. The key publications to reference are from the SELECT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
8 20jason_paloalto, Dr.LeslieOBGYN, MikeNYC_runner and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Jan 20, 2026 at 5:04 AM#24

hank_denver — wow. I've been looking for this exact info for weeks.

9 0Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 6 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jan 20, 2026 at 5:21 AM#25

Adding my data to this FLOW trial semaglutide discussion:

MetricBaselineMonth 5Month 6
Weight240 lbs220 lbs215 lbs
A1C6.4%6.0%5.2%
hsCRP4.04.00.6

Protocol: Semaglutide 1.7mg/wk, resistance training 3x/wk, protein 1.2g/kg/day.

15 1FranDenver, Dr.BariatricHTX, LindaRN_retired and 12 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register